| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.92▼ | 2.96▼ | 2.98▼ | 3.13▼ | 3.39▼ |
| MA10 | 2.95▼ | 2.99▼ | 3.00▼ | 3.33▼ | 3.15▼ |
| MA20 | 2.98▼ | 3.00▼ | 2.98▼ | 3.39▼ | 2.64▲ |
| MA50 | 3.00▼ | 3.07▼ | 3.31▼ | 3.06▼ | 2.82▲ |
| MA100 | 3.00▼ | 3.33▼ | 3.39▼ | 2.56▲ | 3.38▼ |
| MA200 | 3.04▼ | 3.39▼ | 3.41▼ | 2.48▲ | 4.30▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.003▼ | 0.012▲ | -0.100▼ | 0.109▲ |
| RSI | 21.381▼ | 32.908▼ | 29.850▼ | 36.367▼ | 51.285▲ |
| STOCH | 3.571▼ | 19.411▼ | 43.935 | 32.610 | 76.943 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -86.735▼ | -51.295 |
| CCI | -155.298▼ | -244.444▼ | -201.666▼ | -155.972▼ | 24.837 |
|
Monday, July 27, 2015 07:15 AM
Agenus (NYSE:AGEN) has had its Buy rating reiterated by HCWainwright, which set a target price of US$14.00 for the company after GlaxoSmithKline announced that its anti-malaria vaccine RTS, S or Mosqu...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/02/19 | 3.025 | 3.065 | 2.89 | 2.89 | 2,242,841 |
| 21/02/19 | 2.96 | 3.07 | 2.8801 | 2.98 | 2,028,331 |
| 20/02/19 | 3.16 | 3.23 | 2.76 | 2.99 | 4,046,173 |
| 19/02/19 | 3.61 | 3.67 | 3.10 | 3.17 | 3,342,375 |
| 15/02/19 | 3.56 | 3.69 | 3.50 | 3.61 | 1,314,623 |
| 14/02/19 | 3.59 | 3.65 | 3.53 | 3.54 | 736,486 |
| 13/02/19 | 3.56 | 3.66 | 3.52 | 3.61 | 1,077,822 |
| 12/02/19 | 3.49 | 3.575 | 3.455 | 3.57 | 1,014,882 |
| 11/02/19 | 3.51 | 3.55 | 3.425 | 3.48 | 665,613 |
| 08/02/19 | 3.39 | 3.52 | 3.38 | 3.49 | 1,401,056 |
|
|
||||
|
|
||||
|
|
||||
|
|